XML 63 R39.htm IDEA: XBRL DOCUMENT
v3.19.3.a.u2

Warrants and Derivative Liabilities (Detail Textuals) | 1 Months Ended | 3 Months Ended | 9 Months Ended | 12 Months Ended |
--- | --- | --- | --- | --- | ---
Feb. 28, 2018 USD ($) Investor $ / shares shares | Feb. 16, 2018 USD ($) $ / shares shares | Jan. 19, 2018 USD ($) $ / shares shares | Mar. 31, 2019 USD ($) | Sep. 30, 2019 USD ($) shares | Sep. 30, 2018 USD ($) | Dec. 31, 2018 USD ($) | Dec. 31, 2017 USD ($) | Jan. 31, 2017 shares
Class of Warrant or Right [Line Items] |  |  |  |  |  |  |  |  |
Financing transaction costs |  |  |  |  |  | $ (137,192) | $ (137,192) |  |
Warrants issued in connection with convertible multi draw credit agreement related party value |  |  |  | $ 716,110 |  |  | 315,080 |  |
Warrant vested aggregate fair value utilizing the Black-Scholes option pricing model |  |  |  |  | $ (2,024,660) | $ 1,653,477 | 6,503,174 | $ (767,198) |
Warrant |  |  |  |  |  |  |  |  |
Class of Warrant or Right [Line Items] |  |  |  |  |  |  |  |  |
Value of common stock called by warrants | $ 30,000 |  |  |  |  |  |  |  |
Total number of warrants issued | shares | 125,000 |  |  |  |  |  |  |  |
Number of investors | Investor | 1 |  |  |  |  |  |  |  |
Warrants issued in connection with convertible multi draw credit agreement related party value |  |  |  |  |  |  | $ 315,080 |  |
Warrant | Emerald Health Sciences Inc |  |  |  |  |  |  |  |  |
Class of Warrant or Right [Line Items] |  |  |  |  |  |  |  |  |
Number of warrants issued | shares |  |  |  |  | 5,000,000 |  |  |  |
Value of common stock called by warrants | $ 3,400,000 | $ 3,400,000 | $ 40,800,000 |  |  |  |  |  |
Total number of warrants issued | shares | 44,200,000 | 44,200,000 | 44,200,000 |  |  |  |  |  |
Warrant exercise price | $ / shares | $ 0.10 | $ 0.10 | $ 0.10 |  |  |  |  |  |
Term of warrant | 5 years | 5 years | 5 years |  |  |  |  |  |
Warrants issued in connection with convertible multi draw credit agreement related party value |  |  |  |  | $ 716,110 |  |  |  |
Warrant vested aggregate fair value utilizing the Black-Scholes option pricing model |  |  |  |  | $ 1,830,573 |  |  |  |
Series D Preferred Stock | Warrant |  |  |  |  |  |  |  |  |
Class of Warrant or Right [Line Items] |  |  |  |  |  |  |  |  |
Value of common stock called by warrants |  |  |  |  |  |  |  | $ 115,200 |
Total number of warrants issued | shares |  |  |  |  |  |  |  |  | 480,000
Securities purchase agreement | Emerald Health Sciences Inc |  |  |  |  |  |  |  |  |
Class of Warrant or Right [Line Items] |  |  |  |  |  |  |  |  |
Total number of warrants issued | shares |  | 20,400,000 | 20,400,000 |  |  |  |  |  |
Warrant exercise price | $ / shares |  | $ 0.10 | $ 0.10 |  |  |  |  |  |
Term of warrant |  | 5 years |  |  |  |  |  |  |
Securities purchase agreement | Accredited investor | Emerald Health Sciences Inc |  |  |  |  |  |  |  |  |
Class of Warrant or Right [Line Items] |  |  |  |  |  |  |  |  |
Total number of warrants issued | shares |  | 3,400,000 |  |  |  |  |  |  |
Warrant exercise price | $ / shares |  | $ 0.10 |  |  |  |  |  |  |
Term of warrant |  | 5 years |  |  |  |  |  |  |
Emerald Warrant Liabilities |  |  |  |  |  |  |  |  |
Class of Warrant or Right [Line Items] |  |  |  |  |  |  |  |  |
Value of common stock called by warrants |  | $ 5,700,000 | $ 4,700,000 |  |  |  |  |  |

X
- Definition Represents the number of investors. + References No definition available. + Details
Name: | embi_NumberOfInvestors
Namespace Prefix: | embi_
Data Type: | xbrli:integerItemType
Balance Type: | na
Period Type: | instant

X
- Definition Represents term of warrant. + References No definition available. + Details
Name: | embi_TermOfWarrant
Namespace Prefix: | embi_
Data Type: | xbrli:durationItemType
Balance Type: | na
Period Type: | duration

X
- Definition Represents amount of common stock called by warrants. + References No definition available. + Details
Name: | embi_ValueOfCommonStockCalledByWarrants
Namespace Prefix: | embi_
Data Type: | xbrli:monetaryItemType
Balance Type: | na
Period Type: | instant

X
- Definition Represents warrants issued in connection with convertible multi draw credit agreement related party value. + References No definition available. + Details
Name: | embi_WarrantsIssuedInConnectionWithConvertibleMultiDrawCreditAgreementRelatedPartyValue
Namespace Prefix: | embi_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Exercise price per share or per unit of warrants or rights outstanding. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 235 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.4-08.(i)(4)) -URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690 + Details
Name: | us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
Namespace Prefix: | us-gaap_
Data Type: | num:perShareItemType
Balance Type: | na
Period Type: | instant

X
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. + References No definition available. + Details
Name: | us-gaap_ClassOfWarrantOrRightLineItems
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Number of securities into which each warrant or right may be converted. For example, but not limited to, each warrant may be converted into two shares. + References No definition available. + Details
Name: | us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight
Namespace Prefix: | us-gaap_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | instant

X
- Definition Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 235 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.4-08.(i)(2)) -URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690 + Details
Name: | us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
Namespace Prefix: | us-gaap_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | instant

X
- Definition Amount of expense (income) related to adjustment to fair value of warrant liability. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 28 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=109223946&loc=d3e3602-108585 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 480 -SubTopic 10 -Section 25 -Paragraph 13 -URI http://asc.fasb.org/extlink&oid=109262497&loc=d3e20148-110875 + Details
Name: | us-gaap_FairValueAdjustmentOfWarrants
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition The cash outflow for cost incurred directly with the issuance of a derivative security. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 15 -URI http://asc.fasb.org/extlink&oid=109223946&loc=d3e3291-108585 + Details
Name: | us-gaap_PaymentsOfDerivativeIssuanceCosts
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Details
Name: | us-gaap_StatementEquityComponentsAxis=us-gaap_WarrantMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | dei_LegalEntityAxis=embi_EmeraldHealthSciencesIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementClassOfStockAxis=us-gaap_SeriesDPreferredStockMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_TypeOfArrangementAxis=embi_SecuritiesPurchaseAgreementMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_InvestorMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ClassOfWarrantOrRightAxis=embi_EmeraldWarrantLiabilityMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |